Ixazomib citrate
Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor. Ixazomib citrate can be used for the study of a broad range of human malignancies[1][2][3].
Product Specifications
CAS Number
[1239908-20-3]
Product Name Alternative
MLN9708
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; Proteasome
Type
Reference compound
Related Pathways
Autophagy; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MLN9708.html
Concentration
10mM
Purity
99.89
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)CC1(CC(O)=O)OB([C@@H](NC(CNC(C2=CC(Cl)=CC=C2Cl)=O)=O)CC(C)C)OC1=O
Molecular Formula
C20H23BCl2N2O9
Molecular Weight
517.12
Precautions
H302, H315, H319, H335
References & Citations
[1]Demirbilek S, et al. Small-dose capsaicin reduces systemic inflammatory responses in septic rats. Anesth Analg. 2004 Nov;99 (5) :1501-1507.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CDC42EP1 (Cdc42 Effector Protein 1, Binder of Rho GTPases 5, Serum Protein MSE55, BORG5, CEP1, MSE55) (AP)
CDC42EP1 (Cdc42 Effector Protein 1, Binder of Rho GTPases 5, Serum Protein MSE55, BORG5, CEP1, MSE55) (AP)
